Back to User profile » Dr Gang Zhu
Papers published by Dr Gang Zhu:
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Study on the Correlation Between Iris Characteristics and Schizophrenia
Tian C, Duan L, Fu C, He J, Dai J, Zhu G
Neuropsychiatric Disease and Treatment 2022, 18:811-820
Published Date: 8 April 2022
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Phantom Limb Pain and Sensations in Chinese Malignant Tumor Amputees: A Retrospective Epidemiological Study
Jiang S, Zheng K, Wang W, Pei Y, Qiu E, Zhu G
Neuropsychiatric Disease and Treatment 2021, 17:1579-1587
Published Date: 21 May 2021
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Association Between Glutathione Peroxidase-1 (GPx-1) Polymorphisms and Schizophrenia in the Chinese Han Population
Shao X, Yan C, Sun D, Fu C, Tian C, Duan L, Zhu G
Neuropsychiatric Disease and Treatment 2020, 16:2297-2305
Published Date: 6 October 2020
![Noteworthy comment: This case-control study concluded that the GSTM1 null genotype and the GSTM1 and GSTT1 double null genotype may be related to the onset of schizophrenia in the Chinese Han population. This study suggested that the GSTM1 gene polymorphism was one of the risk indicators for schizophrenia, but whether it will be useful as a biomarker for schizophrenia in the East Asian population still requires further exploration in larger samples and multiple regions.](assets/img/article_icons/noteworthy.png)
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Association Between Glutathione S-Transferase (GST) Polymorphisms and Schizophrenia in a Chinese Han Population
Yan C, Duan L, Fu C, Tian C, Zhang B, Shao X, Zhu G
Neuropsychiatric Disease and Treatment 2020, 16:479-487
Published Date: 18 February 2020
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Association between ADORA2A gene polymorphisms and schizophrenia in the North Chinese Han population
Miao J, Liu L, Yan C, Zhu X, Fan M, Yu P, Ji K, Huang Y, Wang Y, Zhu G
Neuropsychiatric Disease and Treatment 2019, 15:2451-2458
Published Date: 28 August 2019
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Topiramate add-on treatment associated with normalization of prolactin levels in a patient with schizophrenia
Huang Y, Ma H, Wang Y, Peng M, Zhu G
Neuropsychiatric Disease and Treatment 2017, 13:1395-1397
Published Date: 24 May 2017
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Functioning in patients with major depression treated with duloxetine or a selective serotonin reuptake inhibitor in East Asia
Novick D, Montgomery W, Haro JM, Moneta MV, Zhu G, Yue L, Hong J, Dueñas H, Brugnoli R
Neuropsychiatric Disease and Treatment 2016, 12:383-392
Published Date: 23 February 2016